ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced Pancreatic Cancer

Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases,updated the Phase 1 study results of IBI343, a novel anti-CLDN18.2 ADC, for the treatment of advanced pancreatic cancer at the 2025 American Society of […]

VINEXPO ASIA 2025 OFFERS CLARITY FOR ASEAN TRADE IN SHIFTING LANDSCAPE

In a shifting global landscape, clarity matters. From 27 to 29 May, Vinexpo Asia 2025 gathered 8,998 trade participants at Marina Bay Sands, reinforcing its position as both a business catalyst and a strategic forum for market orientation and collective foresight. The opening ceremony, attended by Singapore's Minister of State (MOS) for Foreign Affairs and

Deloitte Launches its Asia Pacific Agentic AI Centre of Excellence to Accelerate Scalable, Trusted AI Transformation

— Deloitte launches its Asia Pacific Agentic AI Centre of Excellence, bringing together over 120 AI specialists in the region to help organisations achieve scalable, responsible AI transformation — Agentic AI empowers businesses to automate complex processes, reimagine enterprise value chains and unlock new efficiencies through autonomous digital agents that learn and adapt. — Deloitte

Bragar Eagel & Squire, P.C. Is Investigating EchoStar, Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm

(NASDAQ:SATS),(NASDAQ:ADTN),(NASDAQ:SMLR),(NasdaqGM:FLGT), NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against EchoStar Corporation (NASDAQ:SATS), Semler Scientific Inc. (NASDAQ:SMLR), ADTRAN Holdings, Inc. (NASDAQ:ADTN), and Fulgent Genetics, Inc. (NASDAQ: FLGT). Our investigations concern whether these companies have violated the federal securities laws

Bragar Eagel & Squire, P.C. Is Investigating TechTarget, SelectQuote, GoHealth, and Cleveland-Cliffs and Encourages Investors to Contact the Firm

(NASDAQ:TTGT),(NYSE:SLQT),(NASDAQ:GOCO),(NYSE:CLF), NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims TechTarget, Inc. (NASDAQ:TTGT), SelectQuote, Inc. (NYSE: SLQT), GoHealth, Inc. (NASDAQ:GOCO), and Cleveland-Cliffs Inc. (NYSE:CLF). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Strategy Incorporated, and Organon and Encourages Investors to Contact the Firm

(NASDAQ:DNUT),(NASDAQ:MSTR),(NYSE:OGN), NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Krispy Kreme, Inc. (NASDAQ: DNUT), Strategy Incorporated (NASDAQ:MSTR), and Organon & Co. (NYSE:OGN). Stockholders have until the deadlines below to petition

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance Health, and Iovance and Encourages Investors to Contact the Firm

(NYSE:CODI),(NASDAQ:DMRC),(NYSE:ELV),(NasdaqGM:IOVA), NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Compass Diversified (NYSE:CODI), Digimarc Corporation (NASDAQ:DMRC), Elevance Health, Inc. (NYSE:ELV), and Iovance Biotherapeutics, Inc. (NASDAQ:IOVA). Stockholders have until the deadlines below

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Avis Budget, Civitas, Open Lending, and West Pharmaceutical and Encourages Investors to Contact the Firm

(NASDAQ:CAR),(NYSE:CIVI),(NasdaqGM:LPRO),(NYSE:WST), NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Avis Budget Group, Inc. (NASDAQ:CAR), Civitas Resources, Inc. (NYSE: CIVI), Open Lending Corporation (NASDAQ:LPRO), and West Pharmaceutical Services, Inc. (NYSE:WST). Stockholders

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ibotta, NET Power, Zenas BioPharma, and BigBear and Encourages Investors to Contact the Firm

(NYSE:IBTA),(NYSE:NPWR),(NASDAQ:ZBIO),(NYSE:BBAI), NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ibotta, Inc. (NYSE:IBTA), NET Power, Inc. (NYSE:NPWR), Zenas BioPharma, Inc. (NASDAQ:ZBIO), and BigBear.ai Holdings, Inc. (NYSE:BBAI). Stockholders have until the deadlines

Scroll to Top